Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT02633514
PHASE3
Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma
Sponsor: Fudan University
View on ClinicalTrials.gov
Summary
This study is designed to investigate whether adjuvant radiochemotherapy after incomplete resection has a better survival than adjuvant radiotherapy for thymoma or thymic carcinoma.
Official title: A Randomized Phase III Study of Adjuvant Radiotherapy Versus Adjuvant Radiochemotherapy in Patients With Incomplete ResectionThymoma or Thymic Carcinoma
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
1
Start Date
2023-12-01
Completion Date
2026-12
Last Updated
2023-12-05
Healthy Volunteers
No
Conditions
Interventions
DRUG
Cisplatin
25mg/m2,iv gtt,d1-3
DRUG
Etoposide
75mg/m2,iv gtt,d1-3
RADIATION
radiotherapy
60Gy/30Fx
Locations (1)
Kailiang Wu
Shanghai, Shanghai Municipality, China